Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.

Evason KJ, Grenert JP, Ferrell LD, Kakar S.

Hum Pathol. 2013 May;44(5):750-8. doi: 10.1016/j.humpath.2012.07.019. Epub 2012 Oct 16.

PMID:
23084586
[PubMed - indexed for MEDLINE]
2.

Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD.

Histopathology. 2009 Aug;55(2):197-205. doi: 10.1111/j.1365-2559.2009.03343.x.

PMID:
19694827
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD.

Mod Pathol. 2014 Apr 18. doi: 10.1038/modpathol.2014.50. [Epub ahead of print]

PMID:
24743216
[PubMed - as supplied by publisher]
4.

Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.

Shafizadeh N, Genrich G, Ferrell L, Kakar S.

Hum Pathol. 2014 May;45(5):976-83. doi: 10.1016/j.humpath.2013.12.011. Epub 2014 Jan 8.

PMID:
24746201
[PubMed - indexed for MEDLINE]
5.

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.

Hepatology. 2006 Mar;43(3):515-24.

PMID:
16496320
[PubMed - indexed for MEDLINE]
6.

Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization.

Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH.

J Pathol. 2001 Apr;193(4):476-82.

PMID:
11276006
[PubMed - indexed for MEDLINE]
7.

Malignant transformation of hepatic adenomas.

Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M.

Mod Pathol. 2008 Apr;21(4):491-7. doi: 10.1038/modpathol.2008.8. Epub 2008 Feb 1.

PMID:
18246041
[PubMed - indexed for MEDLINE]
Free Article
8.

Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.

Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L.

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1283-91. Epub 2006 Sep 18.

PMID:
16979954
[PubMed - indexed for MEDLINE]
9.

Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma.

Wilkens L, Bredt M, Flemming P, Mengel M, Becker T, Klempnauer J, Kreipe H.

J Hepatobiliary Pancreat Surg. 2002;9(3):304-11.

PMID:
12353141
[PubMed - indexed for MEDLINE]
10.

Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.

van Dekken H, Verhoef C, Wink J, van Marion R, Vissers KJ, Hop WC, de Man RA, IJzermans JN, van Eijck CH, Zondervan PE.

Acta Histochem. 2005;107(3):161-71.

PMID:
16000213
[PubMed - indexed for MEDLINE]
11.

Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.

Shafizadeh N, Kakar S.

Adv Anat Pathol. 2011 Nov;18(6):438-45. doi: 10.1097/PAP.0b013e318234abb4. Review.

PMID:
21993269
[PubMed - indexed for MEDLINE]
12.

Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.

Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV.

Radiology. 2011 Mar;258(3):673-93. doi: 10.1148/radiol.10100376. Review.

PMID:
21339346
[PubMed - indexed for MEDLINE]
13.

Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.

Hechtman JF, Raoufi M, Fiel MI, Taouli B, Facciuto M, Schiano TD, Blouin AG, Thung SN.

Am J Surg Pathol. 2011 Jun;35(6):927-32. doi: 10.1097/PAS.0b013e318218ca3f. Review.

PMID:
21572265
[PubMed - indexed for MEDLINE]
14.

Subtype classification of hepatocellular adenoma.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J.

Dig Surg. 2010;27(1):39-45. doi: 10.1159/000268406. Epub 2010 Apr 1.

PMID:
20357450
[PubMed - indexed for MEDLINE]
15.

Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.

Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):170-6. doi: 10.1097/PAI.0b013e31825d527f.

PMID:
22914605
[PubMed - indexed for MEDLINE]
16.

Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Nasarek A, Werner M, Nolte M, Klempnauer J, Georgii A.

Virchows Arch. 1995;427(4):373-8.

PMID:
8548121
[PubMed - indexed for MEDLINE]
17.

Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.

Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC.

Oncogene. 1999 Aug 19;18(33):4726-33.

PMID:
10467420
[PubMed - indexed for MEDLINE]
Free Article
18.

Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.

Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP.

Hepatology. 2009 Mar;49(3):821-31. doi: 10.1002/hep.22695.

PMID:
19101982
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.

An FQ, Matsuda M, Fujii H, Tang RF, Amemiya H, Dai YM, Matsumoto Y.

Int J Cancer. 2001 Aug 15;93(4):468-74.

PMID:
11477549
[PubMed - indexed for MEDLINE]
20.

Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.

Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K.

Hepatology. 1999 Jun;29(6):1858-62.

PMID:
10347130
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk